Palvella Therapeutics (PVLA) Price Target Increased by 33.50% to 178.50
The average one-year price target for Palvella Therapeutics (NasdaqCM:PVLA) has been revised to $178.50 / share. This is an increase of 33.50% from the prior estimate of $133.70 dated December…
